The annual general meeting (the "AGM") of Shanghai Pharmaceuticals Holding Co., Ltd. (the "Company") was held at Ocean Energy Hall, 1 st Floor, Shanghai Science Hall, 57 Nanchang Road, Shanghai, the People's Republic of China on 23 June 2017, Friday at 1:00 p.m..

Details of the resolutions considered at the AGM were set out in the notice of the AGM and the circular (the "Circular") of the Company, each dated 9 May 2017. Unless otherwise defined in this announcement, capitalised terms used in this announcement shall have the same meanings as those defined in the Circular.

As at the date of the AGM, the total number of issued Shares of the Company is 2,688,910,538, comprising of 1,923,016,618 A Shares and 765,893,920 H Shares. Holders of such Shares were entitled to attend and vote on the resolutions at the AGM. There were no Shares entitling any Shareholders to attend and vote only against the resolutions proposed at the AGM. To the best knowledge, information and belief of the Directors, no Shareholders were subject to any restriction on their voting on the resolutions proposed at the AGM.

Shanghai Pharmaceuticals Holding Co. Ltd. published this content on 24 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 July 2017 15:14:08 UTC.

Original documenthttp://english.sphchina.com/art/2017/6/24/art_215_6623.html

Public permalinkhttp://www.publicnow.com/view/C50303DB554D79861A76FC15A56B0425C074ECF0